Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
D. Boral Capital is an active, global investment bank headquartered in New York, specializing in financial advisory, capital raising, and strategic growth solutions for clients across multiple industries—including healthcare and life sciences but also energy, technology, real estate, consumer goods, and more. The firm has completed over 500 transactions globally since its founding in 2020 and has raised or advised on over $250 billion in capital. It is led by CEO David W. Boral.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on D. Boral Capital.